药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Halothane
Bencyclane
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Bencyclane.
Halothane
Gallopamil
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Gallopamil.
Halothane
Triclabendazole
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Triclabendazole.
Halothane
Ebastine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Ebastine.
Halothane
Rupatadine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Rupatadine.
Halothane
Niguldipine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Niguldipine.
Halothane
Lacidipine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Lacidipine.
Halothane
Aranidipine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Aranidipine.
Halothane
Pinaverium
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Pinaverium.
Halothane
Dabrafenib
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Dabrafenib.
Halothane
Rilpivirine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Rilpivirine.
Halothane
Delafloxacin
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Delafloxacin.
Halothane
Acrivastine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Acrivastine.
Halothane
Vilanterol
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Vilanterol.
Halothane
Mirabegron
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Mirabegron.
Halothane
Arformoterol
The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Levocetirizine.
Halothane
Cilostazol
The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Levocetirizine.
Halothane
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Pipemidic acid.
Halothane
Rufloxacin
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Rufloxacin.
Halothane
Piromidic acid
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Piromidic acid.